Cannabidiol as a potential treatment for psychosis.
Subject: Schizophrenia - PUBLISHED VIA European Neuropsychopharmacology
Author(s): View Source >> (Price: $36)
Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Published via Current Pharmaceutical Design
Published via Translational Psychiatry
Published via Neuropsychopharmacology
Published via Drug Testing and Analysis
Published via Brazilian Journal of Medical and Biological Research